Skip to main content
Article thumbnail
Location of Repository

Targeting base excision repair to improve cancer therapies

By Ricky A. Sharma and Grigory L. Dianov

Abstract

This is the authors' final draft of the paper published as Molecular Aspects of Medicine, 2007, 28, pp. 345-374. The final definitive version is available from www.sciencedirect.com, doi:10.1016/j.mam.2007.06.002.Most commonly used cancer therapies, particularly ionizing radiation and certain classes of cytotoxic chemotherapies, cause cell death by damaging DNA. Base excision repair (BER) is the major system responsible for the removal of corrupt DNA bases and repair of DNA single strand breaks generated spontaneously and induced by exogenous DNA damaging factors such as certain cancer therapies. In this review, the physico-chemical properties of the proteins involved in BER are discussed with particular emphasis on molecular mechanisms coordinating repair processes. The aim of this review is to apply extensive knowledge that currently exists regarding the biochemical mechanisms involved in human BER to the molecular biology of current therapies for cancer. It is anticipated that the application of this knowledge will translate into the development of novel effective therapies for improving existing treatments such as radiation therapy and oxaliplatin chemotherapy

Publisher: Elsevier
Year: 2007
DOI identifier: 10.1016/j.mam.2007.06.002
OAI identifier: oai:lra.le.ac.uk:2381/2655

Suggested articles

Citations

  1. (2005). A vital role for ape1/ref1 protein in repairing spontaneous DNA damage in human cells. doi
  2. (1994). Aberrant DNA repair and DNA replication due to an inherited enzymatic defect in human DNA ligase I. doi
  3. (2004). AP endonuclease-independent DNA base excision repair in human cells. doi
  4. (2007). Base damage and single-strand break repair: mechanisms and functional significance of short- and long-patch repair subpathways. doi
  5. (1997). Base excision repair deficient mice lacking the Aag alkyladenine DNA glycosylase. doi
  6. (2000). Biphasic kinetics of the human DNA repair protein MED1 (MBD4), a mismatch-specific DNA N-glycosylase. doi
  7. (1988). Characterization of DNA polymerase beta mRNA: cell-cycle and growth response in cultured human cells. doi
  8. (1991). Cloning and Characterization of a 3-Methyladenine DNA Glycosylase Cdna from Human-Cells Whose Gene Maps to Chromosome-16. Proc Nat Acad doi
  9. (1997). Cloning and characterization of a mammalian 8-oxoguanine DNA glycosylase. doi
  10. (1997). Cloning and characterization of hOGG1, a human homolog of the OGG1 gene of Saccharomyces cerevisiae. doi
  11. (1996). Cloning and sequencing a human homolog (hMYH) of the Escherichia coli mutY gene whose function is required for the repair of oxidative DNA damage.
  12. (2001). Combined effects of adenovirus-mediated wild-type p53 transduction, temozolomide and poly (ADP-ribose) polymerase inhibitor in mismatch repair deficient and non-proliferating tumor cells. doi
  13. (2001). Completion of base excision repair by mammalian DNA ligases. doi
  14. (1994). Deletion of a DNA-Polymerase-Beta Gene Segment in T-Cells Using Cell-Type-Specific Gene Targeting. doi
  15. (1996). Differential expression of the apurinic / apyrimidinic endonuclease (APE/ref-1) multifunctional DNA base excision repair gene during fetal development and in adult rat brain and testis. doi
  16. (1999). DNA polymerase beta expression differences in selected human tumors and cell lines. doi
  17. (1998). DNA repair defect in poly(ADP-ribose) polymerase-deficient cell lines. doi
  18. (2005). DNA repair fidelity of base excision repair pathways in human cell extracts. doi
  19. (1998). DNA replication fork in eukaryotic cells. doi
  20. (2001). DNA synthesis and dRPase activities of polymerase beta are both essential for singlenucleotide patch base excision repair in mammalian cell extracts. doi
  21. (2006). Early embryonic lethality due to targeted inactivation of DNA ligase III. doi
  22. (2004). Exchangeability of mammalian DNA ligases between base excision repair pathways. doi
  23. (1994). Expression of a Multifunctional DNA-Repair Enzyme Gene, Apurinic/Apyrimidinic Endonuclease (Ape-Ref-1) in the Suprachiasmatic, Supraoptic and Paraventricular Nuclei. doi
  24. (2005). Expression of DNA polymerase {beta} cancer-associated variants in mouse cells results in cellular transformation. doi
  25. (1998). Fidelity and mutational specificity of uracil-initiated base excision DNA repair synthesis in human glioblastoma cell extracts. doi
  26. (1999). Functional expression of hMYH, a human homolog of the Escherichia coli MutY protein.
  27. (1998). Generation of a strong mutator phenotype in yeast by imbalanced base excision repair. doi
  28. (2004). Genomewide identification of genes conferring resistance to the anticancer agents cisplatin, oxaliplatin, and mitomycin C. doi
  29. (2006). Germline mutations and polymorphic variants in MMR, E-cadherin and MYH genes associated with familial gastric cancer in Jiangsu of China. doi
  30. (2005). Germline susceptibility to colorectal cancer due to base-excision repair gene defects. doi
  31. Growth retardation and immunodeficiency in a patient with mutations in the DNA ligase I gene. doi
  32. (2006). Increased frequency of disease-causing MYH mutations in colon cancer families. doi
  33. (2006). Inhibition of poly(ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma. doi
  34. (1991). Isolation of cDNA clones encoding a human apurinic/apyrimidinic endonuclease that corrects DNA repair and mutagenesis defects in E. coli xth (exonuclease III) mutants. doi
  35. (2005). K-ras as a target for cancer therapy. doi
  36. (2007). Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide. doi
  37. (2002). Mapping of the interaction interface of DNA polymerase beta with XRCC1. doi
  38. (1990). Mismatch-specific thymine DNA glycosylase and DNA polymerase β mediate the correction of G-T mispairs in nuclear extracts from human cells. doi
  39. (1997). Molecular cloning and functional expression of a human cDNA encoding the antimutator enzyme 8-hydroxyguanine-DNA glycosylase. doi
  40. (1990). Molecular cloning of the human XRCC1 gene, which corrects defective DNA repair and sister chromatid exchange. doi
  41. (2004). Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice. doi
  42. (1993). NAD(+)-dependent repair of damaged DNA by human cell extracts.
  43. (2004). Novel inhibitors of poly(ADPribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast.
  44. (2002). Novel nuclear and mitochondrial
  45. (2004). of the Kras oncogene in lung tumors.
  46. (2003). Ogg1 knockout-associated lung tumorigenesis and its suppression by Mth1 gene disruption.
  47. (1997). PARP is important for genomic stability but dispensable in apoptosis. doi
  48. (2005). Parp-1 deficiency causes an increase of deletion mutations and insertions/rearrangements in vivo after treatment with an alkylating agent. doi
  49. (2005). Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region. doi
  50. polymerase beta initiates DNA synthesis during long-patch repair of reduced AP sites in DNA. doi
  51. (2003). Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1. doi
  52. (2002). Repair of dihydrouracil supported by base excision repair in mNTH1 knock-out cell extracts. doi
  53. (1999). Repair of DNA damage in mitochondria. doi
  54. (1999). Requirement for the Xrcc1 DNA base excision repair gene during early mouse development. doi
  55. (1996). Requirement of mammalian DNA polymerase-β in baseexcision repair. doi
  56. (2005). REV1 mediated mutagenesis in base excision repair deficient mouse fibroblast. doi
  57. (1992). Role of poly(ADP-ribose) formation in DNA repair. doi
  58. (1998). Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. doi
  59. (2006). Roles of base excision repair subpathways in correcting oxidized abasic sites in DNA. doi
  60. (2001). SMUG1 No U, OHMeU (Boorstein et al.,
  61. (2004). Stable down-regulation of human polynucleotide kinase enhances spontaneous mutation frequency and sensitizes cells to genotoxic agents. doi
  62. (1998). Structure and function of mammalian DNA ligases. doi
  63. (2003). Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.
  64. (2005). Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. doi
  65. (2000). The efficiency and fidelity of translesion synthesis past cisplatin and oxaliplatin GpG adducts by human DNA polymerase beta. doi
  66. (2005). The intracellular localization of APE1/Ref-1: more than a passive phenomenon? doi
  67. (2001). The major human abasic endonuclease: formation, consequences and repair of abasic lesions in DNA. doi
  68. (1996). The redox/DNA repair protein, Ref-1, is essential for early embryonic development in mice. doi
  69. (2001). The world according to PARP. doi
  70. (1996). Two pathways for base excision repair in mammalian cells.
  71. XRCC1 co-localizes and physically interacts with PCNA. doi
  72. (2001). XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. doi
  73. (2000). XRCC1 keeps DNA from getting stranded. doi
  74. (2001). XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA singlestrand break repair. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.